Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians.

Tytuł:
Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians.
Autorzy:
Albitar L; Department of Pharmaceutics, Faculty of Pharmacy, Arab International University, Damascus, Syria.
Alchamat GA; Department of Biology, Faculty of Science, Damascus University, Damascus, Syria. .
Źródło:
BMC health services research [BMC Health Serv Res] 2021 Oct 01; Vol. 21 (1), pp. 1031. Date of Electronic Publication: 2021 Oct 01.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: London : BioMed Central, [2001-
MeSH Terms:
Pharmacists*
Physicians*
Female ; Health Knowledge, Attitudes, Practice ; Humans ; Male ; Pharmacogenetics ; Surveys and Questionnaires ; Syria
References:
Clin Pharmacol Ther. 2012 Mar;91(3):450-8. (PMID: 22278335)
Fundam Clin Pharmacol. 2015 Jun;29(3):219-37. (PMID: 25817555)
Genomic Med. 2008 Dec;2(3-4):101-5. (PMID: 19363698)
G Ital Nefrol. 2010 Jul-Aug;27(4):353-66. (PMID: 20672232)
J Oncol Pharm Pract. 2020 Dec;26(8):1836-1842. (PMID: 32131682)
J Pers Med. 2020 Nov 09;10(4):. (PMID: 33182317)
Oncotarget. 2018 May 18;9(38):25355-25382. (PMID: 29861877)
Pharmacogenomics. 2013 Jun;14(8):957-68. (PMID: 23746189)
Risk Manag Healthc Policy. 2020 Aug 21;13:1279-1291. (PMID: 32904476)
Clin Cases Miner Bone Metab. 2009 Jan;6(1):17-24. (PMID: 22461093)
PLoS One. 2018 Sep 5;13(9):e0203033. (PMID: 30183746)
Am J Med Genet C Semin Med Genet. 2014 Mar;166C(1):8-14. (PMID: 24616394)
Am J Pharm Educ. 2011 Apr 11;75(3):51. (PMID: 21655405)
Pharmgenomics Pers Med. 2017 Dec 05;10:279-285. (PMID: 29255371)
Pharmacogenomics. 2019 Jun;20(9):643-657. (PMID: 31250730)
Rev Neurol. 2004 Dec 1-15;39(11):1063-71. (PMID: 15597270)
Saudi Pharm J. 2021 Jan;29(1):53-58. (PMID: 33603539)
Per Med. 2016 Mar;13(2):143-154. (PMID: 29749903)
Pharmacogenomics. 2017 Feb;18(3):215-225. (PMID: 28112992)
Pharmgenomics Pers Med. 2019 Oct 07;12:247-255. (PMID: 31632127)
Pharmacogenomics. 2010 Sep;11(9):1331-40. (PMID: 20860470)
Per Med. 2020 Jul 1;17(4):251-260. (PMID: 32589096)
J Hum Genet. 2020 May;65(5):437-444. (PMID: 31983733)
BMC Med Genomics. 2015;8 Suppl 1:S3. (PMID: 25951871)
Pharmgenomics Pers Med. 2015 Jan 29;8:35-41. (PMID: 25691815)
Drug Resist Updat. 2018 Jul;39:18-40. (PMID: 30075835)
Pharmacogenomics. 2010 Jan;11(1):105-11. (PMID: 20017676)
J Pharm Sci. 2017 Sep;106(9):2368-2379. (PMID: 28619604)
J Eval Clin Pract. 2015 Aug;21(4):703-9. (PMID: 25929423)
Per Med. 2014 Jan;11(1):15-26. (PMID: 29751393)
Eur J Clin Pharmacol. 2017 Oct;73(10):1247-1252. (PMID: 28669097)
Pharmgenomics Pers Med. 2020 Nov 16;13:601-617. (PMID: 33235483)
Pharmacy (Basel). 2017 Jun 30;5(3):. (PMID: 28970448)
Pharmacogenomics. 2006 Dec;7(8):1175-84. (PMID: 17184205)
Eur J Clin Pharmacol. 2010 Aug;66(8):755-74. (PMID: 20582584)
Ned Tijdschr Geneeskd. 2010;154:A1503. (PMID: 20699026)
P T. 2010 Oct;35(10):560-76. (PMID: 21037908)
Contributed Indexing:
Keywords: Drug response; Genetic variations; Knowledge assessment; Pharmacogenetic testing; Pharmacogenetics
Entry Date(s):
Date Created: 20211001 Date Completed: 20211004 Latest Revision: 20211005
Update Code:
20240105
PubMed Central ID:
PMC8485485
DOI:
10.1186/s12913-021-07040-9
PMID:
34592972
Czasopismo naukowe
Background: Pharmacogenetics targets genetic variations that influence drug response. It is relatively a new science that has not been vastly employed in most developing countries including Syria. Therefore we aimed at evaluating the depth of knowledge in pharmacogenetics and the attitude towards it amongst Syrian pharmacists and physicians.
Methods: We carried out an internet-based questionnaire consisted of 26 questions, sent through specialized websites and private groups with a large number of pharmacists and physicians members. The survey was available online for a period of 1 month.
Results: The total number of respondents was 154, mostly female pharmacists. Our statistical analysis showed a strong positive association between profession (in favour of pharmacists) and pharmacogenetics knowledge p = 0.049; however, no correlation with experience p = 0.811 was found. A significant difference was reported between the knowledge of pharmacists and physicians p = 0.001 concerning drugs that need pharmacogenetics testing before being prescribed. The majority of respondents had no information about applying genetic tests in Syria before prescribing medications nor did they possess the knowledge regarding drugs that show differential responses in patients according to their unique genotypes. In our study, the percentage knowledge assessment score was low in general (mean ± Standard deviation, SD) (46% ± 13.9%). The majority of the respondents agreed that pharmacists should provide counselling to patients on the subject of pharmacogenetics. Respondents' opinions varied concerning making pharmacogenetics learning a priority.
Conclusion: Lack of pharmacogenetics knowledge was found amongst respondents in general. Our findings raise concerns about the lack of awareness amongst physicians, which may hinder the implementation of this crucial field in Syria. We suggest an emphasis on the role of education, training, and conducting genotyping research on the Syrian population.
(© 2021. The Author(s).)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies